<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00497211</url>
  </required_header>
  <id_info>
    <org_study_id>EC 3/39/123</org_study_id>
    <nct_id>NCT00497211</nct_id>
  </id_info>
  <brief_title>Intracoronary Infusion of BM-Derived Mononuclear Cells in Patients With Large Acute Myocardial Infarction</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Large acute myocardial infarctions are the most frequent cause of subsequent systolic heart&#xD;
      failure. Some evidence exists on the improvement after intracoronary administration of bone&#xD;
      marrow cells in patients with a recente acute myocardial infarction. Although subgroup&#xD;
      analyses suggest that patients with the largest myocardial infarctions have the largest&#xD;
      increase in ejection fraction after intracoronary bone marrow administration, there is no&#xD;
      published trial including only large myocardial infarctions. Therefor we sought to confirm&#xD;
      the subgroup analyses by conducting a trial in only large first acute myocardial infarction&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <condition>Myocardial Infarction</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intracoronary mononuclear cell infusion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age â‰¥20 and &lt;80 years old&#xD;
&#xD;
          -  Acute myocardial infarction &gt;2 and &lt;96 hours from start to reperfusion&#xD;
&#xD;
          -  Cumulative ST-segment elevation &gt;6 mm on 12 lead ECG&#xD;
&#xD;
          -  No functional myocardial impairment outside the myocardial infarction region&#xD;
&#xD;
          -  Succesful PCI of infarct related coronary artery&#xD;
&#xD;
          -  Left ventricular ejection fraction &lt;50% on ventriculography, echo or MRI&#xD;
&#xD;
          -  Accepted anticonceptive use during the study for women of childbearing potential&#xD;
&#xD;
          -  Written and signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  CPR &gt; 10 minuts or persistent cardiogenic shock&#xD;
&#xD;
          -  complete left bundle branch block without concordant ST-segment elevation&#xD;
&#xD;
          -  Need foor cardiac surgery (valvular, coronary or other)&#xD;
&#xD;
          -  Trombocytopenia, coagulation disorders or hematological disease&#xD;
&#xD;
          -  History or active malignancy&#xD;
&#xD;
          -  Life expectancy (apart from acute myocardial infarction) &lt;5 years&#xD;
&#xD;
          -  Dialysis or severe kidney insufficiency (creatinin clearance &lt;30ml/')&#xD;
&#xD;
          -  Severe liver insufficiency&#xD;
&#xD;
          -  Severe respiratory disease&#xD;
&#xD;
          -  Systemic inflammatory pathology (acute or chronic, apart from inflammation associated&#xD;
             with myocardial infarction)&#xD;
&#xD;
          -  Symptomatic cerebral or periferal vascular disease&#xD;
&#xD;
          -  Prior myocardial infarction or prior myocardial dysfunction&#xD;
&#xD;
          -  Prior CABG or heart valve surgery&#xD;
&#xD;
          -  Pregnancy, pregnancy wish or lactation &lt;1 month&#xD;
&#xD;
          -  Psychiatrical illness&#xD;
&#xD;
          -  Physical or psychological inability to adhere to the protocol&#xD;
&#xD;
          -  Participation in other not yet completed study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven E Haine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Antwerpen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chris Vrints, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>UZ Antwerpen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steven E Haine, MD</last_name>
    <phone>0032.3.821.42.81</phone>
    <email>steven.haine@uza.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Myriam Michiels, Nurse</last_name>
    <phone>0032.3.821.33.04</phone>
    <email>Myriam.michiels@uza.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Antwerpen</name>
      <address>
        <city>Edegem</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Johan Bosmans, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc Claeys, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hielko Miljoen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2007</verification_date>
  <study_first_submitted>July 4, 2007</study_first_submitted>
  <study_first_submitted_qc>July 5, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2007</study_first_posted>
  <last_update_submitted>July 5, 2007</last_update_submitted>
  <last_update_submitted_qc>July 5, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 6, 2007</last_update_posted>
  <keyword>First large acute myocardial infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

